IndraLab

Statements

USP4-C311A leads to the deubiquitination of p38. 1 / 1

| 1

reach

"USP4 (C311A) mutation did not inhibit the TAK1 polyubiquitination, and phosphorylation of TAK1, = JNK1/2, and p38 in angiotensin treated myocytes."

30186311

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP4-C311A leads to the deubiquitination of p38. 1 / 1

INDRA sources:

Databases

Reading